Skip to main content
Premium Trial:

Request an Annual Quote

Immucor Buying Femtoarrays Developer Sentilus

NEW YORK (GenomeWeb) – Transfusion and transplantation diagnostics firm Immucor announced on Wednesday its acquisition of Sentilus for an undisclosed amount.

Durham, NC-based Sentilus was founded in 2012 and is developing an inkjet-printed antibody microarray-based technology called Femtoarrays for use in in vitro diagnostics, including transfusion diagnostics.

Immucor President and CEO William Hawkins said that the Femtoarrays technology "will underpin a full complement of next-generation immunohematology assays. Additionally, we believe the technology has the potential for broad application throughout in vitro diagnostics."

Immucor is headquartered in Norcross, Ga. In May, the US Food and Drug Administration approved the Immucor Precise Type Human Erythrocyte Antigen Molecular BeadChip Test for blood compatibility determination.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.